Ricevi le ultime notizie sulle azioni Lantheus Holdings con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di LNTH

Ultime notizie per

LANTHEUS HOLDINGS INC

Lantheus Holdings

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

Lantheus Holdings Inc

News

Legal

Press Releases

LNTH Deadline Approaching on November 10, 2025: Kessler Topaz Meltzer & Check, LLP Reminds Lantheus Holdings, Inc. (LNTH) Investors of Class Action Lawsuit Deadline

Lantheus Holdings, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before November 10, 2025 to Discuss Your Rights – LNTH

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Lantheus Holdings, Inc.  of Class Action Lawsuit and Upcoming Deadlines - LNTH

ROSEN, A RESPECTED AND LEADING FIRM, Encourages Lantheus Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LNTH

Lantheus Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LNTH

LNTH Investors Have Opportunity to Lead Lantheus Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Class Action Filed Against Lantheus Holdings, Inc. (LNTH) Seeking Recovery for Investors - Contact The Gross Law Firm

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Lantheus Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines – LNTH

Class Action Filed Against Lantheus Holdings, Inc. (LNTH) - November 10, 2025 Deadline to Join – Contact Levi & Korsinsky

LNTH Investors Have Opportunity to Lead Lantheus Holdings, Inc. Securities Fraud Lawsuit

LNTH

Alcon

Align Technology

Avanos Medical

Bausch & Lomb

Bioventus

Cerus

The Cooper Companies, Inc. - Common Stock

Cooper Companies

Embecta

Establishment Labs Holdings Inc. - Common Shares

Establishment Labs Hldgs

Haemonetics

ICU Medical

OrthoPediatrics

Merit Medical Systems, Inc. - Common Stock

Merit Medical Systems

Neogen

InspireMD

OraSure Technologies, Inc. - Common Stock

OraSure Technologies

RxSight

Sanara MedTech

Solventum

Staar Surgical

Sharps Technology

UFP Technologies

Utah Medical Products, Inc. - Common Stock

Utah Medical Products

Dentsply Sirona

Xtant Medical Holdings, Inc. Common Stock

Xtant Medical Hldgs

Goldman Sachs

B. Riley Securities

TD Cowen

Truist Securities

JMP Securities

Comments

Lantheus Holdings Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO